5-APB-NBOMe

5-APB-NBOMe
Clinical data
Other names	5APB-NBOMe; N-MOB-5-APB; N-(2-Methoxybenzyl)-5-(2-aminopropyl)benzofuran
ATC code	None;
Identifiers
	IUPAC name 1-(1-benzofuran-5-yl)-N-[(2-methoxyphenyl)methyl]propan-2-amine;
CAS Number	2055348-17-7;
PubChem CID	138858150;
ChemSpider	52085582;
UNII	YCQ8K7YA07;
CompTox Dashboard (EPA)	DTXSID301342096 ;
Chemical and physical data
Formula	C19H21NO2
Molar mass	295.382 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(C=C1)OC=C2)NCC3=CC=CC=C3OC;
	InChI InChI=1S/C19H21NO2/c1-14(20-13-17-5-3-4-6-18(17)21-2)11-15-7-8-19-16(12-15)9-10-22-19/h3-10,12,14,20H,11,13H2,1-2H3; Key:NSWWDACHSBMHLV-UHFFFAOYSA-N;

5-APB-NBOMe, also known as N-(2-methoxybenzyl)-5-(2-aminopropyl)benzofuran, is a drug of the phenethylamine, amphetamine, benzofuran, and 25-NB (NBOMe) families related to the entactogen and mildly psychedelic drug 5-APB.^[1]^[2]^[3] It is the N-(2-methoxybenzyl) derivative of 5-APB.^[4]^[5]^[3] The preclinical pharmacokinetics of 5-APB-NBOMe have been studied.^[4] The drug was encountered as a novel designer drug in Germany in 2014.^[2]^[6]^[4]^[5]